- Home
- ANVS vs MAPS Comparison
ANVS vs MAPS Comparison
Compare ANVS & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | MAPS |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | 449 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 75.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANVS | MAPS |
|---|---|---|
| Price | $2.29 | $0.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.50 | $2.61 |
| AVG Volume (30 Days) | 1.4M | ★ 6.1M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.17 |
| P/E Ratio | ★ N/A | $9.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $0.32 |
| 52 Week High | $5.50 | $1.36 |
Technical Indicators
Market Signals| Indicator | ANVS | MAPS |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 33.93 |
| Support Level | $1.92 | $0.33 |
| Resistance Level | $2.67 | $0.75 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 87.35 | 12.23 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About MAPS WM Technology Inc.
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.